The present invention relates to polyethylene glycol derivatives having a controlled release nitric oxide as well as their use as drugs. It has been surprisingly found that is possible connect physically or by chemical bonds polyethylene glycol nitrate with pharmacologically active molecules, such as anti-inflammatory, antitumoral drugs, peptides, proteins and oligonucleotides thus obtaining compounds having a better activities profile.